Skip to main navigation Skip to search Skip to main content

Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))

  • Nancy E. Hernandez
  • , Wojciech Jankowski
  • , Rahel Frick
  • , Simon P. Kelow
  • , Joseph H. Lubin
  • , Vijaya Simhadri
  • , Jared Adolf-Bryfogle
  • , Sagar D. Khare
  • , Roland L. Dunbrack
  • , Jeffrey J. Gray
  • , Zuben E. Sauna
  • United States Food and Drug Administration
  • Johns Hopkins University
  • Fox Chase Cancer Center
  • University of Pennsylvania
  • Rutgers - The State University of New Jersey, New Brunswick
  • Institute for Protein Innovation

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032] (Heliyon (2023) 9(4), (S2405844023022399), (10.1016/j.heliyon.2023.e15032))'. Together they form a unique fingerprint.
Sort by

Veterinary Science and Veterinary Medicine